Jazz Pharmaceuticals, Inc. (NASDAQ:JAZZ)

CAPS Rating: 4 out of 5

A specialty pharmaceutical company, which focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry.

JAZZ News and Commentary

View All JAZZ News and Commentary

Caps

How do you think JAZZ will perform against the market?

Add Stock to CAPS Watchlist

All Players

310 Outperform
67 Underperform
 

All-Star Players

70 Outperform
15 Underperform
 

Wall Street

17 Outperform
1 Underperform
 

Top JAZZ Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

grankh (57.99)
Submitted October 21, 2013

Another stock I own personally.Sales have grown 80% per year on average since 2010. EPS has grown 56% over the past 18 months. The profit margin has fluctuated considerably, so not joy there. The earned-on-equity has fallen in each of the past 2… More

ross812 (53.34)
Submitted March 05, 2010

Garbage. Garbage. Garbage!!! See what happens if they fail a drug trial!

JAZZ VS S&P 500 (SPY)

Fools bullish on JAZZ are also bullish on:

Fools bearish on JAZZ are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about JAZZ.

Recs

0
Member Avatar jdkosmicki (< 20) Submitted: 5/15/2017 10:16:51 PM : Outperform Start Price: $155.24 JAZZ Score: -6.56

Undervalued

Recs

0
Member Avatar MaestroFool (93.45) Submitted: 1/30/2017 8:37:19 AM : Outperform Start Price: $119.42 JAZZ Score: +17.04

As I continue learning more about biotech... Jazz is looking inexpensive at less than 11x forward earnings. The stock is 40% off its all-time high of $192 in the summer of 2015. Robust pipeline and they're filing for several exciting approvals in 2017: U.S. approval for Vyexos (to treat leukemia) in Q1 and European approval for the drug in the second half of the year; JZP-110 (to treat sleepiness associated with narcolepsy and sleep apnea); and a new indication for Xyrem in Q4.

Recs

0
Member Avatar genedom (94.35) Submitted: 8/12/2016 3:56:39 PM : Outperform Start Price: $136.52 JAZZ Score: -3.69

Short term over value.

Leaderboard

Find the members with the highest scoring picks in JAZZ.

Score Leader

OriginalJackass

OriginalJackass (96.51) Score: +4,184.02

The Score Leader is the player with the highest score across all their picks in JAZZ.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
OriginalJackass 96.51 6/22/2009 Outperform 5Y $3.39 +4,359.59% +175.57% +4,184.02 0 Comment
GXMR 64.04 6/18/2009 Outperform 1Y $3.80 +3,882.09% +174.12% +3,707.97 0 Comment
Hedonism 86.83 6/29/2009 Outperform 5Y $4.00 +3,679.50% +172.68% +3,506.82 0 Comment
october92008 84.52 10/9/2008 Outperform NS $4.05 +3,632.84% +157.45% +3,475.39 0 Comment
TrackMikeSmith 98.67 10/29/2009 Outperform 5Y $6.09 +2,382.43% +137.64% +2,244.79 0 Comment
keithtarbi 70.92 8/24/2009 Outperform 3W $6.25 +2,318.88% +141.90% +2,176.98 1 Comment
MarinaBoy < 20 7/29/2009 Outperform 3Y $6.30 +2,299.68% +158.55% +2,141.13 0 Comment
tigress73 < 20 8/5/2009 Outperform 1Y $6.41 +2,258.50% +149.25% +2,109.25 0 Comment
mtamom < 20 7/16/2008 Outperform NS $6.75 +2,139.70% +111.88% +2,027.83 0 Comment
39272x5 90.64 11/9/2009 Outperform 5Y $6.96 +2,072.13% +131.56% +1,940.57 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJanney 84.42 4/6/2017 Outperform NS $150.00 +0.79% +6.40% -5.61 0 Comment
TrackSunTrustRH 87.05 4/25/2016 Outperform NS $160.00 -5.51% +20.03% -25.54 0 Comment
TrackJimCramer 84.80 3/16/2016 Underperform 3W $120.97 +24.97% +22.93% -2.04 0 Comment
trackbuckingham 44.27 7/23/2014 Outperform NS $148.00 +2.15% +25.93% -23.78 0 Comment
TrackJMP 84.46 6/17/2014 Outperform NS $143.26 +5.53% +28.84% -23.31 0 Comment
TrackWellsFargo 91.49 6/11/2014 Outperform NS $142.02 +6.45% +28.26% -21.81 0 Comment
TrackCanaccord 62.44 4/17/2014 Outperform NS $137.20 +10.19% +34.48% -24.29 0 Comment
TrackUBS 93.49 12/6/2013 Outperform NS $116.76 +29.48% +38.36% -8.88 0 Comment
TrackStifel 94.60 5/31/2013 Outperform NS $68.42 +120.96% +51.16% +69.80 0 Comment
TrackCantorFitz 37.25 3/11/2013 Outperform NS $59.68 +153.32% +60.93% +92.38 0 Comment
TrackLazardCapit 81.35 1/18/2013 Outperform NS $56.75 +166.40% +68.93% +97.46 0 Comment
TrackCowenandCo 87.81 9/11/2012 Outperform NS $44.86 +237.00% +74.07% +162.93 0 Comment
TrackJimCramer 84.80 8/16/2012 Outperform 3W $47.77 +153.23% +43.21% +110.03 3/16/2016 @ $120.97 0 Comment
TrackZacks < 20 6/14/2012 Outperform 3M $43.06 +23.01% +3.51% +19.50 11/9/2012 @ $52.97 1 Comment
TrackCreditSuiss 91.66 5/23/2012 Outperform NS $43.96 +243.90% +90.45% +153.45 0 Comment
TrackCitigroup 93.16 4/10/2012 Outperform NS $50.11 +201.68% +81.20% +120.48 0 Comment
trackmizuho < 20 1/6/2012 Outperform NS $43.05 +251.17% +94.98% +156.19 0 Comment
TrackUltraLong 21.45 11/3/2011 Outperform NS $38.17 +296.07% +99.54% +196.53 1 Comment
TrackAurigaUSA 48.54 9/30/2011 Outperform NS $41.37 +265.43% +118.41% +147.02 0 Comment
TrackJimCramer 84.80 11/8/2010 Underperform 3W $14.97 +219.10% +15.92% -203.19 8/16/2012 @ $47.77 0 Comment
TrackBarclaysCap 91.65 6/15/2010 Outperform NS $8.50 +1,678.59% +124.11% +1,554.48 0 Comment
trackwbbsecuriti < 20 5/17/2010 Outperform NS $8.72 +335.78% +10.32% +325.46 12/8/2011 @ $38.00 0 Comment
TrackJefferies 83.31 3/4/2010 Outperform NS $11.01 -3.91% +3.56% -7.46 10/12/2010 @ $10.58 0 Comment
TrackBarclaysCap 91.65 6/26/2009 Underperform NS $4.13 +106.54% +20.98% -85.56 6/15/2010 @ $8.53 0 Comment
TrackLehmanBros < 20 7/11/2007 Outperform NS $16.44 +172.20% -8.41% +180.61 4/17/2012 @ $44.75 0 Comment